Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Strata Oncology
AddedFeb 15, 2024
UpdatedJun 18, 2026
Strata Oncology

Strata Oncology

Series C

Strata Oncology: Transforming cancer care through precision medicine and accelerated drug approval.

HQ
Ann Arbor, MI, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Strata Oncology, founded with a mission to revolutionize cancer care, focuses on expanding patient access to precision medicine clinical trials and accelerating drug approval processes. The company offers a national precision oncology platform that connects patient screening with streamlined enrollment in mutation-matched clinical trials. Strata Oncology's services cater to patients, healthcare providers, and biopharmaceutical companies, aiming to personalize immunotherapy treatments for all solid tumors.

Notable figures affiliated with Strata Oncology include leading experts in oncology and precision medicine, though specific names are not provided. The company has achieved significant milestones in enhancing the efficiency of clinical trials and improving patient outcomes through its innovative platform. Strata Oncology's impact is evident in its contribution to the faster approval of new cancer therapies and the broader adoption of precision medicine in oncology.

Strata Oncology - Similar Companies

OncoPrecision logo

OncoPrecision

oncoprecision.bio

GenomOncology logo

GenomOncology

genomoncology.com

Onc.AI logo

Onc.AI

onc.ai

Certis Oncology Solutions logo

Certis Oncology Solutions

certisoncology.com

Triomics logo

Triomics

triomics.com

xCures logo

xCures

xcures.com

Massive Bio logo

Massive Bio

massivebio.com

Clinical Platform logo

Clinical Platform

Oncobox logo

Oncobox

oncobox.com

Champions Oncology logo

Champions Oncology

Predictive Oncology logo

Predictive Oncology

D2G Oncology logo

D2G Oncology

d2g-oncology.com

Precision Health AI logo

Precision Health AI

Strategikon Pharma logo

Strategikon Pharma

Leal Health logo

Leal Health

leal.health

Strata Oncology - Quick Facts

Who are Strata Oncology's competitors?

Companies similar to Strata Oncology include OncoPrecision, GenomOncology, Onc.AI and Certis Oncology Solutions.

When was Strata Oncology founded?

Strata Oncology was founded in 2016.

Where is Strata Oncology's headquarters located?

Strata Oncology's headquarters is located in Ann Arbor, MI, US.

When was Strata Oncology's last funding round?

Strata Oncology's most recent funding round was for $90M (USD) in July 2021.

How much has Strata Oncology raised to-date?

As of Jul 28, 2021, Strata Oncology has raised a total of $128M (USD).

How many employees does Strata Oncology have?

Strata Oncology has 90 employees as of Feb 5, 2024.

Strata Oncology - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Clinical Trials
  • Oncology
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified